- Home
- ZYXI vs GOSS Comparison
ZYXI vs GOSS Comparison
Compare ZYXI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- GOSS
- Stock Information
- Founded
- ZYXI 1996
- GOSS 2015
- Country
- ZYXI United States
- GOSS United States
- Employees
- ZYXI N/A
- GOSS N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- GOSS Health Care
- Exchange
- ZYXI Nasdaq
- GOSS Nasdaq
- Market Cap
- ZYXI 257.1M
- GOSS 230.8M
- IPO Year
- ZYXI N/A
- GOSS 2019
- Fundamental
- Price
- ZYXI $7.52
- GOSS $0.98
- Analyst Decision
- ZYXI Strong Buy
- GOSS Strong Buy
- Analyst Count
- ZYXI 2
- GOSS 5
- Target Price
- ZYXI $13.50
- GOSS $9.20
- AVG Volume (30 Days)
- ZYXI 95.3K
- GOSS 939.3K
- Earning Date
- ZYXI 10-24-2024
- GOSS 11-07-2024
- Dividend Yield
- ZYXI N/A
- GOSS N/A
- EPS Growth
- ZYXI N/A
- GOSS N/A
- EPS
- ZYXI 0.18
- GOSS N/A
- Revenue
- ZYXI $193,614,000.00
- GOSS $95,842,000.00
- Revenue This Year
- ZYXI $11.68
- GOSS N/A
- Revenue Next Year
- ZYXI $20.90
- GOSS N/A
- P/E Ratio
- ZYXI $41.49
- GOSS N/A
- Revenue Growth
- ZYXI 9.11
- GOSS N/A
- 52 Week Low
- ZYXI $7.04
- GOSS $0.45
- 52 Week High
- ZYXI $13.77
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- ZYXI 42.26
- GOSS 50.68
- Support Level
- ZYXI $7.61
- GOSS $0.98
- Resistance Level
- ZYXI $7.99
- GOSS $1.09
- Average True Range (ATR)
- ZYXI 0.28
- GOSS 0.06
- MACD
- ZYXI -0.03
- GOSS -0.00
- Stochastic Oscillator
- ZYXI 11.63
- GOSS 26.14
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.